University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent
|
|||||
Gut microbes cultured in an artistic design (Nicola Fawcett, Wikimedia Commons) 18 June 2018. Researchers from a biotechnology company and a research institute are starting a joint project to find treatments for Parkinson’s disease targeting bacteria in the gut. Financial and intellectual property aspects of the partnership between Axial Biotherapeutics Inc. in Boston, and . . . → Read More: Biotech, Institute Partner on Gut Microbe Links to Parkinson’s 
A group of geo- and bioscience researchers analyzed microbes residing in soil under northern California and discovered many new potential sources of antibiotics, well beyond current sources. . . . → Read More: Soil Microbes Yield Rich Antibiotic Sources 
A combination of natural bacteria found in milk products and a synthetic variation of those microbes are shown in tests with lab mice to detect and prevent cholera infections. . . . → Read More: Natural, Engineered Microbes Shown to Control Cholera 
A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer. . . . → Read More: Hospital Network Formed for Childhood Cancer Immunotherapies 
Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research 
The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease. . . . → Read More: NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell 
A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases. . . . → Read More: Single Technology Produces Vaccines for Multiple Infectious Diseases 
A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs  One comment - (Comments are closed)  New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital 
Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries Comments are closed New products biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals, stem cells, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
